(Q46664230)

24 December 2017

title

Molecular heterogeneity in prostate cancer: can TP53 mutation unravel tumorigenesis? (English)

1 reference

24 December 2017

author name string

Roy-Burman P

series ordinal

1

1 reference

24 December 2017

Zheng J

series ordinal

2

1 reference

24 December 2017

Miller GJ

series ordinal

3

1 reference

24 December 2017

publication date

1 November 1997

1 reference

24 December 2017

Trends in Molecular Medicine

published in

1 reference

24 December 2017

volume

3

1 reference

24 December 2017

issue

11

1 reference

24 December 2017

page(s)

476-482

1 reference

24 December 2017

Carcinoma of the prostate

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

Chromosomal abnormalities and related events in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

Molecular foundations of cancer: New targets for intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

Clonal origin of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

The clonal evolution of tumor cell populations

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

DNA heterogeneity determined by flow cytometry in prostatic adenocarcinoma--necessitating multiple site analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

P53, cell cycle control and apoptosis: Implications for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

Apoptosis, cancer and the p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

Alterations of the P53 gene are associated with the progression of a human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

p53 in prostate cancer: frequent expressed transition mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

p53 protein and gene alterations in pathological stage C prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

Gain of function mutations in p53.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

Life (and death) in a malignant tumour

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901126-X

7 January 2021

10.1016/S1357-4310(97)01126-X

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017